In the last 12 months, insiders at BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) filed 43 transactions with the SEC: 13 open-market purchases totaling $283,114 and 1 sales totaling $22,069. Net insider sentiment: net buying.
BRAINSTORM CELL THERAPEUTICS INC. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Lebovits Chaim (President & CEO) — 26 transactions totaling $554,920
- Dagher Ibrahim B. (Chief Medical Officer) — 2 transactions totaling $22,069
- Lindborg Stacy (Director) — 1 transaction totaling $0
- Patlis Alla (See Remarks) — 2 transactions totaling $0
- ARBEL IRIT (Director) — 1 transaction totaling $0
View all SEC Filings for BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2025 | Dagher Ibrahim B. | Chief Medical Officer | A | Common Stock | 50000 | $0.00 | 79,515.0000 | 5,021,798 | 169.41% | 1.00% |
| Jan. 1, 2025 | Lebovits Chaim | President & CEO | A | Common Stock | 120000 | $0.00 | 334,349.0000 | 5,021,798 | 55.98% | 2.39% |
| Jan. 1, 2025 | FRENKEL JACOB A | Director | A | Common Stock | 40000 | $0.00 | 43,777.0000 | 5,021,798 | 1059.04% | 0.80% |
| Jan. 1, 2025 | Polverino Anthony J. | Director | A | Common Stock | 24000 | $0.00 | 25,730.0000 | 5,021,798 | 1387.28% | 0.48% |
| Jan. 1, 2025 | Yablonka Uri | EVP & Chief Business Officer | A | Common Stock | 40000 | $0.00 | 48,464.0000 | 5,021,798 | 472.59% | 0.80% |
| Jan. 1, 2025 | Yablonka Uri | EVP & Chief Business Officer | A | Common Stock | 20000 | $0.00 | 68,464.0000 | 5,021,798 | 41.27% | 0.40% |
| Jan. 1, 2025 | Patlis Alla | See Remarks | A | Common Stock | 40000 | $0.00 | 44,349.0000 | 5,021,798 | 919.75% | 0.80% |
| Jan. 1, 2025 | Naor Nir | Director | A | Common Stock | 30666 | $0.00 | 31,465.0000 | 5,021,798 | 3838.05% | 0.61% |
| Jan. 1, 2025 | Lindborg Stacy | Director | A | Common Stock | 20000 | $0.00 | 48,229.0000 | 5,021,798 | 70.85% | 0.40% |
| Jan. 1, 2025 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A | Common Stock | 50000 | $0.00 | 52,000.0000 | 5,021,798 | 2500.00% | 1.00% |
| Jan. 1, 2025 | Bairu Menghisteab | Director | A | Common Stock | 24000 | $0.00 | 24,000.0000 | 5,021,798 | 9999.99% | 0.48% |
| Jan. 1, 2025 | ARBEL IRIT | Director | A | Common Stock | 30666 | $0.00 | 41,054.0000 | 5,021,798 | 295.21% | 0.61% |
| Sept. 30, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 22000 | $0.23 | 1,320,254.0000 | 4,747,699 | 1.69% | 0.46% |
| Oct. 1, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 1836 | $3.43 | 214,349.0000 | 5,309,796 | 0.86% | 0.03% |
| May 13, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 10000 | $0.49 | 3,100,712.0000 | 4,315,903 | 0.32% | 0.23% |
| May 28, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 15000 | $0.52 | 3,165,712.0000 | 4,315,903 | 0.48% | 0.35% |
| May 21, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 25000 | $0.58 | 3,125,712.0000 | 4,315,903 | 0.81% | 0.58% |
| May 22, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 25000 | $0.64 | 3,150,712.0000 | 4,315,903 | 0.80% | 0.58% |
| May 10, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 20000 | $0.47 | 3,080,712.0000 | 4,315,903 | 0.65% | 0.46% |
| May 11, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 10000 | $0.47 | 3,090,712.0000 | 4,315,903 | 0.32% | 0.23% |
| May 7, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 66300 | $0.37 | 3,060,712.0000 | 4,315,903 | 2.21% | 1.54% |
| May 6, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 135000 | $0.38 | 2,994,412.0000 | 4,315,903 | 4.72% | 3.13% |
| April 19, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 15000 | $0.52 | 2,859,412.0000 | 4,315,903 | 0.53% | 0.35% |
| April 17, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 130000 | $0.55 | 2,729,340.0000 | 4,315,903 | 5.00% | 3.01% |
| April 18, 2024 | Lebovits Chaim | President & CEO | P | Common Stock | 115072 | $0.53 | 2,844,412.0000 | 4,315,903 | 4.22% | 2.67% |
| July 19, 2024 | Dagher Ibrahim B. | Chief Medical Officer | S | Common Stock | 63000 | $0.35 | 190,000.0000 | 4,747,699 | 24.90% | 1.33% |
| June 24, 2024 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 4,315,903 | 9999.99% | 1.39% |
| June 24, 2024 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A | Common Stock | 30000 | $0.00 | 30,000.0000 | 4,315,903 | 9999.99% | 0.70% |
| May 28, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 15000 | $0.52 | 3,165,712.0000 | 4,315,903 | 0.48% | 0.35% |
| May 22, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 25000 | $0.64 | 3,150,712.0000 | 4,315,903 | 0.80% | 0.58% |
| May 21, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 25000 | $0.58 | 3,125,712.0000 | 4,315,903 | 0.81% | 0.58% |
| May 11, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 10000 | $0.47 | 3,090,712.0000 | 4,315,903 | 0.32% | 0.23% |
| May 10, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 20000 | $0.47 | 3,080,712.0000 | 4,315,903 | 0.65% | 0.46% |
| May 13, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 10000 | $0.49 | 3,100,712.0000 | 4,315,903 | 0.32% | 0.23% |
| May 6, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 135000 | $0.38 | 2,994,412.0000 | 4,315,903 | 4.72% | 3.13% |
| May 7, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 66300 | $0.37 | 3,060,712.0000 | 4,315,903 | 2.21% | 1.54% |
| April 19, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 15000 | $0.52 | 2,859,412.0000 | 4,315,903 | 0.53% | 0.35% |
| April 17, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 130000 | $0.55 | 2,729,340.0000 | 4,315,903 | 5.00% | 3.01% |
| April 18, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 115072 | $0.53 | 2,844,412.0000 | 4,315,903 | 4.22% | 2.67% |
| March 11, 2024 | Patlis Alla | See Remarks | A | Common Stock | 65246 | $0.00 | 65,246.0000 | 2,871,729 | 9999.99% | 2.27% |
| March 11, 2024 | Yablonka Uri | EVP & Chief Business Officer | A | Common Stock | 109426 | $0.00 | 126,969.0000 | 2,871,729 | 623.76% | 3.81% |
| March 11, 2024 | Lindborg Stacy | Co-Chief Executive Officer | A | Common Stock | 241935 | $0.00 | 423,435.0000 | 2,871,729 | 133.30% | 8.42% |
| March 11, 2024 | Lebovits Chaim | President & CEO | A | Common Stock | 305198 | $0.00 | 2,599,340.0000 | 2,871,729 | 13.30% | 10.63% |